INSIGHTS ON ENTERPRISE SOLUTIONS
-
![cell-and-gene-therapy-GettyImages-2272229186]( "From Laboratory To Launchpad: Japan's Cell And Gene Therapy Ecosystem Hits Its Stride")
From Laboratory To Launchpad: Japan's Cell And Gene Therapy Ecosystem Hits Its StrideJapan is emerging as a credible cell and gene therapy hub as regulation, manufacturing, and capital advance, despite gaps in funding, talent, risk culture, and language.
-
![Advancing Drug Product Manufacturing With A Risk-Based Approach]( "Advancing Drug Product Manufacturing With A Risk-Based Approach")
Advancing Drug Product Manufacturing With A Risk-Based ApproachSingle-use systems are now standard, yet expectations for their use keep shifting. Integrity assurance across the lifecycle underpins a contamination control strategy that can withstand review.
-
![Closing The Gap Between Biomarker Data And Clinical Proof-Of-Mechanism In Neurodegenerative Disease]( "Linking Biomarkers To Clinical Proof-Of-Mechanism")
Linking Biomarkers To Clinical Proof-Of-MechanismProving CNS delivery and target engagement in neurodegenerative therapies requires aligned clinical pharmacology and bioanalysis, from model selection to validated assays.
-
![Leachables Peptide Stability]( "Science-Driven Risk Mitigation In Single-Use Drug Product Processing")
Science-Driven Risk Mitigation In Single-Use Drug Product ProcessingExplore how extractables and leachables from single-use systems can affect peptide stability, as well as how science-led approaches to component selection can reduce risk throughout manufacturing.
-
The Checklist For Evaluating In-Vivo CAR-T Manufacturing Partners10/16/2026
Choosing the right in vivo CAR-T manufacturing partner requires looking beyond cost to the capabilities that protect scalability, compliance, safety, and development timelines.
-
See How Fill4Sure Works10/16/2026
Dedicated fill lines for each needle eliminate the need to perform line splitting, minimizing the risk of fluid-path bottlenecks, cavitation for sensitive drug products, and structural weak points in assembly integrity.
-
A Tool-Box Approach On Antibody Purification And ADC Conjugation10/15/2026
Controlled cysteine conjugation of a bispecific antibody at DAR 6 and a click chemistry dual-payload conjugate at DAR 8 show how a modular approach handles emerging ADC modalities.
-
Quality And Inspection Readiness: A Daily Commitment To Excellence10/15/2026
Sustained compliance depends less on audit preparation than on everyday habits, from internal assessments to governance gates that catch problems early and staff prepared to engage inspectors.
ENTERPRISE SOLUTIONS
-
![GettyImages-1409877704-antibody]( "Column Care Strategy And Buffer Preparation Support For Biologics Manufacturing")
Variability in column care and buffer preparation grows as biologics processes scale. Defined, ready-to-use solutions support reproducibility across purification workflows and manufacturing scale-up.
-
![Greenfield - Sodium Hydroxide Solutions]( "Sodium Hydroxide Solutions For Pharmaceutical Manufacturing")
Outsourced sodium hydroxide preparation supports column care, pH adjustment, and CIP with multi-compendial inputs and flexible packaging, reducing on-site handling of concentrated, corrosive material.
-
![GettyImages-2178829362-glp-1-protein-3d-render]( "Go Further In GLP-1 Analogue Manufacturing")
Manufacturing chemically synthesized GLP-1 analogues for injection means holding purity and formulation stability together, from chromatography and precipitation through tangential flow filtration.
-
![bioprocess-single-use-GettyImages-2235582082]( "Custom Single-Use Filling Solutions For Bioprocessing")
Custom single-use filling assemblies support drug-specific processes with validated components and sterility assurance, from bench-top to commercial scale.
-
![mRNA iStock-1295693748]( "The Early Advantage For mRNA")
Developing mRNA treatments requires expertise in process development and LNP encapsulation for small biotech companies.
